HK Stock Market Move | Zhongju Investment (01959) surged more than 16% in the final trading session. The company officially completed its name change today and is partnering with Tangmei International to explore the AI beauty market.
Focus Media Investment (01959) soared more than 16% at the close, rising 15.34% as of the press release, to 3.76 Hong Kong dollars, with a turnover of 114.99 million Hong Kong dollars.
China Resources Investment (01959) surged more than 16% at the close, rising 15.34% as of press time to HK$3.76, with a turnover of HK$114.99 million.
In terms of news, CENT UNIT HLDG announced that the Chinese stock abbreviation traded on the Stock Exchange will be changed from "CENT UNIT HLDG" to "China Resources Investment" and will take effect from 9 am on March 4. In addition, China Resources Investment signed a memorandum of understanding with Tangmei International, planning to carry out deep strategic investment in the fields of large health, AI technology, anti-aging, and global channel expansion.
China Resources Investment stated that this cooperation will leverage Tangmei International's leading technology in AI technology anti-aging, mature channels, and global brand influence to quickly enter the AI beauty anti-aging consumption track, expand the global business layout of "physical + digital finance". Both parties will leverage their respective resource advantages to jointly explore the capital operation of AI technology anti-aging projects, promote the scale landing of the global market, build a diversified profit growth engine, and further enhance overall competitiveness.
Related Articles

HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.

MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.

Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.

MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.

Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.

RECOMMEND





